Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia

Added 255 days ago (04.01.2021)
Authors: Zeidner, J. F., Lee, D. J., Frattini, M., Fine, G. D., Costas, J., Kolibaba, K., Anthony, S. P., Bearss, D., Smith, B. D.
Read article